NSTG

NanoString Technologies, Inc. (NSTG) | Rumor.io

NanoString Technologies

NSTG

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about NSTG?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% 0	0% 0

Mar 28

NanoString Technologies' spatial biology technology was featured in National Geographic Magazine to study cell death in Alzheimer's disease.
The technology was used to examine the progression of Alzheimer's disease at the cellular level.
The article highlighted the potential of spatial biology to improve our understanding of complex diseases.

Generated by AI

Sentiment

Of the messages about NSTG that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	70.37% -13.41
Bearish	—	—	—	29.63% +13.41

Bullish· Feb 9

$NSTG has seen significant price appreciation, with a 26.44% gain on the day and a 13.64% gain, indicating strong investor interest.
The stock has experienced abnormal buying pressure, suggesting institutional involvement, which could be a bullish indicator for continued growth.
Shares of $NSTG have gained more than 89% since the last post, indicating a strong upward trend that may continue, with potential for further gains.

Bearish· Feb 5

NanoString Technologies' Chapter 11 bankruptcy filing has caused a significant decline in its share price, with a loss of approximately 70% in value.
The company's management has been criticized for taking large retention bonuses just before filing for bankruptcy, raising concerns about their decision-making and prioritization of investor interests.
The bankruptcy filing has resulted in a massive decline in the company's market capitalization, with its current value sitting at around $6 million.

Generated by AI

Topics

Of the messages about NSTG that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	0%	0%	0%	0%
Announcements	100%	100%	100%	87.5%
Controversies	0%	0%	0%	0%
Earnings	0%	0%	0%	0%
Macro	0%	0%	0%	0%
Technical Analysis	0%	0%	0%	12.5%

Earnings· Mar 7

$NSTG reports Q4 EPS of -$0.34, beating estimates by $0.08, and revenue of $35.23M, exceeding expectations by $3.98M.
Revenue growth is 39.6% year-over-year, with shares declining by 0.5% after the earnings release.
NanoString Technologies guides FY18 EPS below consensus, while FY17 revenue guidance falls short of market expectations.

Announcements· Feb 9

$NSTG entered into a credit agreement with existing lenders, securing $12.5M in new term loans and an additional $35M contingent on court approval.
The credit facility aims to support NanoString Technologies' restructuring process.
$NSTG completed its financing, securing funds to support its restructuring efforts.

Generated by AI

Community

Of the messages about NSTG, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	28.21%
Newcomers	100%	100%	100%	71.79%

Regulars· Feb 12

Already 40.2M shares of NanoString Technologies $NSTG traded today, exceeding the float of 39.4M shares.
A float rotation of 31.0% in $NSTG has been observed, with a new float of 44.3M and a short interest of 12.5%.
The float rotation in $NSTG has resulted in a gain of 31.0% for investors.

Newcomers· Feb 12

Newcomers to the market are focused on understanding the dynamics of the stock price, such as the impact of news and volume on the float.
Some users are analyzing the performance of NanoString Technologies, Inc. (NSTG) and comparing it to other stocks, noting similarities in price movements.
Others are highlighting the asset's recent performance, with one user noting a 12% increase in the stock price.

Generated by AI

Also Discussed

Investors talking about NSTG also mention

#	Name	Attention
1	10x Genomics Inc. Class A Common StockTXG	0%-0.02
2	Veracyte, Inc.VCYT	0%new
3	Twist Bioscience CorporationTWST	0%-0.02
4	NVTA - Invitae Corporation	——
5	Syros Pharmaceuticals Inc.SYRS	0%0
6	AKYA - Akoya Biosciences, Inc.	——
7	AXDX - Accelerate Diagnostics, Inc.	——
8	Pacific Biosciences of California, Inc. Common StockPACB	0%0
9	OMIC - Singular Genomics Systems, Inc.	——
10	CNXA - Connexa Sports Technologies Inc.	——